Cargando…
Combined anticancer activity of osthole and cisplatin in NCI-H460 lung cancer cells in vitro
Drug combination therapies are common practice in the treatment of cancer. Cisplatin is the most active chemotherapeutic agent for lung cancer treatment. Osthole is a natural compound extracted from a number of medicinal plants. To determine whether osthole enhances the anticancer effect of cisplati...
Autores principales: | XU, XIAO-MAN, ZHANG, YI, QU, DAN, LIU, HONG-BO, GU, XIU, JIAO, GUANG-YU, ZHAO, LI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570148/ https://www.ncbi.nlm.nih.gov/pubmed/23404433 http://dx.doi.org/10.3892/etm.2013.889 |
Ejemplares similares
-
Metformin synergistically enhances antiproliferative
effects of cisplatin and etoposide in NCI-H460 human lung cancer cells
por: Teixeira, Sarah Fernandes, et al.
Publicado: (2013) -
Sufentanil impairs autophagic degradation and inhibits cell migration in NCI-H460 in vitro
por: Jiang, Hui, et al.
Publicado: (2019) -
Diallyl Trisulfide Inhibits Growth of NCI-H460 in Vitro and in Vivo, and Ameliorates Cisplatin-Induced Oxidative Injury in the Treatment of Lung Carcinoma in Xenograft Mice
por: Jiang, Xiaoyan, et al.
Publicado: (2017) -
Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin
por: Branco, Helena, et al.
Publicado: (2022) -
Luteolin exerts an anticancer effect on NCI-H460 human non-small cell lung cancer cells through the induction of Sirt1-mediated apoptosis
por: MA, LIPING, et al.
Publicado: (2015)